NYSE · Drug Manufacturers - Specialty & Generic

Hims Hers Health Inc (HIMS)

$30.92 +10.19%
Add alert
57 In band Daily RSI (14) · 9 Oct 2026

Moving averages

SMA 50$29.45+4.99%
SMA 200$27.39+12.89%
EMA 20$29.23+5.78%

Company profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$7.21B
P/E ratioNone
EPS$-0.64
Beta2.432
Dividend yield0.00%
52-week high$65.30
52-week low$13.74

Latest news

HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces
Bearish WBOC TV 3 days ago
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Bearish PR Newswire 3 days ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers
Bearish GlobeNewswire 4 days ago

Earnings call transcript

Q2 2026

Hello, everyone. Thank you for joining us and welcome to the Hims & Hers Health Second Quarter 2026 earnings call. I will now turn the conference over to Bill Newby, Director of Investor Relations. Bill, please go ahead.…

Continue with Google
Unlock the earnings call transcript

Options chain

TypeStrikeExpiryVolumeOpen interest
Call$30.002026-10-099,0614,353
Call$31.002026-10-167,4355,648
Call$31.002026-10-096,5642,955
Continue with Google
Unlock the options chain

Similar stocks in Drug Manufacturers - Specialty & Generic

CGC Canopy Growth Corporation RSI 28 BFRI Biofrontera Inc RSI 36 TLRY Tilray Brands Inc - Class 2 RSI 33 LNTH Lantheus Holdings Inc RSI 48 ACB Aurora Cannabis Inc RSI 67 BCRX Biocryst Pharmaceuticals Inc RSI 49 INM InMed Pharmaceuticals Inc RSI 50 ORGO Organogenesis Holdings Inc - Class A RSI 33 ZTS Zoetis Inc - Class A RSI 57 AQST Aquestive Therapeutics Inc RSI 52
Free forever

RSI alerts for HIMS

Get an email the moment Hims Hers Health Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 11 October 2026 at 9:15 PM EDT